Table 2.
Microbiome | Company | Overview | Project | Stages |
---|---|---|---|---|
Plant | Pivot Bio | Nitrogen fixation | Corn supplement | Commercialized |
AgBiome | Pest control | Fungicide | Commercialized | |
Boost Biomes | Manage disease of high-value crops | Reduce crop loss in the field and post-harvest | In development | |
Animal | Native Microbials | Restore highfunctioning lumen | Dairy | Commercialized |
Other animals | In development | |||
AnimalBiome | Personalized FMT | Pet dogs and cats | Commercialized | |
Human | Evelo Biosciences | Monoclonal microbials | COVID-19 | Phase II/III |
Psoriasis | Phase II | |||
Triple-negative breast cancer | Preclinical | |||
Vedanta Biosciences | Defined consortia | Clostridium difficile infection | Phase II | |
Inflammatory bowel disease | Phase I | |||
Cancer immunotherapy | Phase I | |||
Food allergy | Phase I | |||
Seres Therapeutics | Defined consortia | C. difficile infection | Phase III | |
Ulcerative colitis | Phase II | |||
Metastatic melanoma | Phase I | |||
Synlogic Therapeutics | Smart living biotherapeutics | Phenylketonuria | Phase II | |
Immune-oncology solid tumors | Phase I |
Abbreviation: COVID-19, coronavirus disease 2019; FMT, fecal microbiota transplantation.